Bu bilgiler yalnızca eğitim amaçlıdır. Her zaman bir sağlık uzmanına danışın. Daha fazla bilgi
Drug Safety & Regulation · 8 dk okuma

Controlled Substances and DEA Schedules

A clear explanation of the five DEA drug schedules, how substances are classified, and what scheduling means for how drugs are prescribed and dispensed.

What Is a Controlled Substance?

A controlled substance is a drug or chemical whose manufacture, possession, and use are regulated by the federal government under the Controlled Substances Act (CSA) of 1970. The CSA was enacted to reduce drug abuse and dependence by classifying substances based on their medical utility and potential for abuse.

Two federal agencies share responsibility for regulating controlled substances:

  • The Drug Enforcement Administration (DEA): Enforces the CSA, maintains the scheduling system, and regulates who may manufacture, distribute, prescribe, and dispense controlled substances.
  • The FDA: Evaluates scientific and medical evidence to recommend scheduling decisions and weighs in on rescheduling petitions.

Importantly, a drug can be both FDA-approved (meaning it has accepted medical uses) and controlled (meaning its use is restricted due to abuse potential). Most prescription opioids, stimulants, and benzodiazepines are in this category.

The Five DEA Schedules

Controlled substances are divided into five schedules (I through V) based on two factors: accepted medical use and potential for abuse and dependence.

Schedule I: No Accepted Medical Use

Schedule I substances are defined as having no currently accepted medical use in the United States, a high potential for abuse, and a lack of accepted safety for use under medical supervision.

Common Schedule I substances include heroin, LSD, psilocybin (magic mushrooms), MDMA (ecstasy), and — controversially — marijuana (cannabis) at the federal level.

Because Schedule I substances have no accepted medical use by definition under federal law, they cannot be prescribed by physicians. Research using Schedule I substances requires special DEA registration and is heavily restricted, which many scientists argue has hindered study of potentially beneficial compounds.

Note: Individual states may have their own scheduling systems, and some have legalized or decriminalized cannabis despite its federal Schedule I status.

Schedule II: High Abuse Potential, Accepted Medical Use

Schedule II substances have high potential for abuse that may lead to severe psychological or physical dependence, but they have accepted medical uses.

Examples include: - Opioids: Oxycodone (OxyContin), hydrocodone (Vicodin), fentanyl, morphine, methadone - Stimulants: Amphetamine (Adderall), methylphenidate (Ritalin), methamphetamine (Desoxyn, used medically for obesity) - Cocaine: Used medically as a topical anesthetic in ear, nose, and throat surgery

Schedule II drugs cannot be refilled — each prescription must be a new, signed prescription from the prescriber. Many states require prescribers to use a special tamper-resistant prescription pad or an electronic prescribing for controlled substances (EPCS) system.

Schedule III: Moderate Abuse Potential

Schedule III substances have less potential for abuse than Schedule I or II, and abuse may lead to moderate or low physical dependence or high psychological dependence.

Examples include: - Anabolic steroids: Testosterone (prescribed for hypogonadism, gender-affirming care) - Ketamine: A dissociative anesthetic now also approved for treatment-resistant depression (esketamine/Spravato) - Combination opioid products with limited opioid content: Tylenol with Codeine #3 (acetaminophen 300 mg + codeine 30 mg) - Buprenorphine: Used for opioid use disorder treatment (Suboxone, Subutex) and pain

Schedule III prescriptions may be refilled up to 5 times within 6 months.

Schedule IV: Low Abuse Potential

Schedule IV substances have low potential for abuse relative to Schedule III and have accepted medical uses.

Examples include: - Benzodiazepines: Diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin) - Sleep aids: Zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata) - Tramadol: A synthetic opioid pain reliever - Carisoprodol: A muscle relaxant

Like Schedule III, these may be refilled up to 5 times within 6 months.

Schedule V: Lowest Abuse Potential

Schedule V substances have the lowest abuse potential of all controlled substances and contain limited quantities of certain narcotics.

Examples include: - Cough preparations with less than 200 mg of codeine per 100 mL (such as Robitussin AC) - Pregabalin (Lyrica): Used for nerve pain, fibromyalgia, and epilepsy - Lacosamide (Vimpat): An anticonvulsant

Some Schedule V preparations may be available without a prescription in certain states (subject to pharmacist oversight), though prescriptions are also common.

How Is a Drug Scheduled?

A drug's schedule can change over time based on new evidence. The rescheduling process may be initiated by:

  • The DEA itself
  • The FDA
  • The Department of Health and Human Services (HHS)
  • A petition from any interested party (manufacturer, researcher, medical organization, advocacy group)

The DEA evaluates eight specific factors, including: 1. The drug's actual or relative potential for abuse 2. Scientific evidence of its pharmacological effects 3. Current state of scientific knowledge about the drug 4. History and current pattern of abuse 5. Scope, duration, and significance of abuse 6. Risk to public health 7. Psychic or physiological dependence liability 8. Whether the substance is an immediate precursor to an already-scheduled substance

The FDA provides a scientific and medical evaluation to the DEA as part of the process.

What Scheduling Means for Prescriptions

The schedule directly affects how a drug can be prescribed and dispensed:

Feature Schedule II Schedule III–IV Schedule V
Refills allowed No Up to 5 in 6 months Varies by state
Phone/fax prescriptions Limited (emergency only) Generally allowed Generally allowed
Quantity limits Common (30-day supply) Varies Varies
Special prescription forms Often required Usually not No
Prescription monitoring Mandatory (PDMP) Mandatory (PDMP) Often required

Prescription Monitoring Programs

All 50 states now operate Prescription Drug

A medication that legally requires a healthcare provider's prescription before dispensing. Prescription-only status is assigned when a drug's risks require professional supervision — due to side effec

Monitoring Programs (PDMPs) — electronic databases that track controlled substance prescriptions dispensed within the state. When you fill a controlled substance prescription, the dispensing pharmacist submits that information to the PDMP.

Prescribers are generally required (in most states) to check the PDMP before prescribing Schedule II–IV drugs, allowing them to identify potential misuse patterns, doctor shopping, and dangerous drug combinations. PDMPs are a cornerstone of opioid prescribing oversight.

Scheduling Controversies

The DEA scheduling system has been criticized from multiple directions:

  • Cannabis (marijuana): Remains Schedule I under federal law despite being legal for medical or recreational use in most states and having substantial evidence of medical benefits for pain, chemotherapy-induced nausea, and other conditions. In 2024, the DEA proposed rescheduling cannabis to Schedule III — a significant potential shift that was still under review as of this writing.
  • Psychedelics for mental health: Psilocybin and MDMA have shown remarkable results in clinical trials for treatment-resistant depression, PTSD, and addiction. Their Schedule I status has historically made research difficult, though FDA approval pathways are now being pursued.
  • Kratom: A plant used by many for pain management and opioid withdrawal. Proposals to schedule it as Schedule I have been contested by patients who use it therapeutically.

Key Takeaways

  • The DEA classifies controlled substances into five schedules based on medical use and abuse potential.
  • Schedule I: No medical use (heroin, LSD, cannabis federally). Schedule II: High abuse risk but medical use (opioids, Adderall). Schedules III–V: Decreasing abuse risk.
  • Schedule II drugs cannot be refilled and have the strictest prescribing controls.
  • PDMPs track all controlled substance prescriptions in real time to prevent misuse.
  • Scheduling is not permanent — drugs can be rescheduled as scientific evidence evolves.

This guide is for educational purposes only. It does not replace professional medical advice. Always consult your healthcare provider before making changes to your medication regimen.

İlgili Sözlük Terimleri

Bu Araçları Deneyin